Skip to content

Research and Application of Artificial Intelligence Robot in Microwave Ablation of Breast

Research and Application of Artificial Intelligence Robot in Microwave Ablation of Breast

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059364
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Tumor

Interventions

Group one:Microwave Ablation

Sponsors

First Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18-75; 2. Tumor diagnosed as BI-RADS grade 3 by breast ultrasound, or determined as grade 3 by conventional ultrasound BI-RADS grade 4a and grade 3 by contrast-enhanced ultrasound or breast MRI; For those aged >= 35 years, the BI-RADS grade of mammography is grade 3 or below; 3. Patients with benign tumors confirmed by core needle biopsy; 4. For multiple tumors, considering the evaluation of breast MRI, the following conditions must be met: the longest diameter measured by ultrasound and contrast-enhanced ultrasound is 1-3cm; The distance from the tumor to the skin/pectoralis major muscle is greater than 0.5cm.

Exclusion criteria

Exclusion criteria: 1. The tendency of severe bleeding; 2. Breast prosthesis; 3. The pathological diagnosis of biopsy is not clear, or it is clinically suspected that the pathological diagnosis of biopsy may be underestimated, including lobulated tumor, papilloma, atypical hyperplasia, sclerosing adenosis, etc; 4. Those who have serious primary diseases and are not suitable for operation; 5. Those who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
Volume Reduction Ratio;Solidity;Recurrence;Skin burn;

Countries

China

Contacts

Public ContactJiandong Wang

First Medical Center of Chinese PLA Gezneral Hospital

wangjiandong@188.com+86 13910269069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026